Globus Medical (NYSE: GMED) reported Q4 EPS of $0.38, $0.03 better than the analyst estimate of $0.35. Revenue for the quarter came in at $176 million versus the consensus estimate of $166.53 million.

GUIDANCE:

Globus Medical sees FY2018 EPS of $1.50, versus the consensus of $1.43. Globus Medical sees FY2018 revenue of $690 million, versus the consensus of $684.7 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.